Lumicell aims to reduce repeat surgeries in breast cancer
Lumicell's technology makes cancer cell at the margins of healthy tissue light up providing real time information during surgery of whether all the suspect tissue is being removed in one go.
Lumicell's technology makes cancer cell at the margins of healthy tissue light up providing real time information during surgery of whether all the suspect tissue is being removed in one go.
Spirox, based in Menlo Park, California, is traveling down the well-worn path of bringing a minimally invasive approach to complex surgery through a new device.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CMS is supporting the incorporation of FDA's unique device identifiers in insurance claims forms, a boon to medical researchers who would receive a bounty of data about medical device safety and effectiveness.
Ananda Devices CEO talks about plans for expanding its organ-on-a-chip tech from researching spinal cord injuries to neurological diseases such as multiple sclerosis.
There are many thousands of genetic tests out there but many of them are useful for research purposes and aren't clinically relevant.
At the center of the scientists' concerns is the lack of studies of transcranial direct stimulation at the frequencies many end users experiment with — for example, stimulating daily for months or longer.
It’s likely that lower-end versions will be made available over the coming years, but how long is that?
Dr. Todd O’Brien is trying to develop and commercialize a smartphone app that can be used at the point of care to identify fractures on the athletic field, combat field or any other site of traumatic injury.
Neuromodulation is gaining ground as a therapy for reducing pain, but no one has yet harnessed it within the cardiology arena, putting the company in a unique position if the Barostim gains FDA approval and commercial success.
Can a mobile health app to automatically detect plaque and inflamed gums create better dental patients?
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
LDR said cervical disc replacement typically occurs in patients who are too young to receive Medicare, making Mobi-C reimbursement a point of contention with private players.
Many of the digital health companies in the Challenge Cup competition are attempting to solve healthcare challenges in developing markets.
The market leader in cancer panel gene testing flooded the zone at the annual meeting of the American Society of Clinical Oncology in Chicago.
A low-cost, connected continuous glucose monitor that can provide clinical decision support seems like it would be a nice addition to the toolset of Diabeter, a Danish operator of Diabetes clinics, which Medtronic acquired last year.
The partnership is a win for Fitchet’s plan to turn around J&J’s slow-growing device unit by partnering with external players.